In yesterday’s Wall Street session, CVS Health Corp (NYSE:CVS) shares traded at $55.00, up 1.31% from the previous session.
CVS stock price is now 6.59% away from the 50-day moving average and -3.50% away from the 200-day moving average. The market capitalization of the company currently stands at $69.21B.
On December 03, 2024, Deutsche Bank Upgraded its previous ‘Hold’ rating to ‘Buy’ on the stock keeping its target price maintained at $66, while ‘Wells Fargo’ rates the stock as ‘Overweight’
In other news, LUDWIG EDWARD J, Director bought 1,000 shares of the company’s stock on May 02 ’24. The stock was bought for $53,879 at an average price of $53.88. Upon completion of the transaction, the Director now directly owns 21,630 shares in the company, valued at $1.19 million. An SEC document containing details of the transaction can be found on the SEC’s website. On May 02 ’24, Director Mahoney Michael F bought 9,181 shares of the business’s stock. A total of $500,294 was incurred on buying the stock at an average price of $54.49. This leaves the insider owning 9,356 shares of the company worth $0.51 million. A total of 0.41% of the company’s stock is owned by insiders.
During the past 12 months, CVS Health Corp has had a low of $43.56 and a high of $80.75. As of last week, the company has a debt-to-equity ratio of 1.10, a current ratio of 0.80, and a quick ratio of 0.59. The fifty day moving average price for CVS is $51.682 and a two-hundred day moving average price translates $57.0583 for the stock.
The latest earnings results from CVS Health Corp (NYSE: CVS) was released for 2024-09-30. The net profit margin was 1.36% and return on equity was 6.72% for CVS. The company reported revenue of $95.43 billion for the quarter, compared to $89.76 billion a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 6.31 percent. For the current quarter, analysts expect CVS to generate $96.88B in revenue.
